Curaleaf Holdings (CURLF) Cash & Equivalents (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Cash & Equivalents of $101.6 million for Q4 2025, down 5.27% year-over-year from $107.2 million in Q4 2024, and down 5.27% quarter-over-quarter from $107.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Cash & Equivalents (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $101.6 million for Q4 2025.
- In Q4 2025, Cash & Equivalents fell 5.27% year-over-year to $101.6 million; the TTM figure through Dec 2025 stood at $101.6 million (down 5.27% YoY), while the FY2025 annual figure was $101.6 million, down 5.27% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $101.6 million, down from $107.2 million in the prior quarter.
- The five-year high for Cash & Equivalents was $333.8 million in Q2 2021, with the low at $73.5 million in Q4 2021.
- The 5-year median for Cash & Equivalents is $107.2 million (2024), against an average of $174.2 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents jumped 307.02% in 2022, then tumbled 69.33% in 2023.
- Curaleaf Holdings' Cash & Equivalents stood at $73.5 million in 2021, then surged by 307.02% to $299.3 million in 2022, then sank by 69.33% to $91.8 million in 2023, then increased by 16.78% to $107.2 million in 2024, then slipped by 5.27% to $101.6 million in 2025.
- Business Quant data shows CURLF's Cash & Equivalents at $101.6 million in Q4 2025, $107.2 million in Q4 2024, and $90.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn | 94.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.59 Mn |
| Dec 31, 2025 | 101.57 Mn |
| Dec 31, 2024 | 107.23 Mn |
| Sep 30, 2024 | 89.97 Mn |
| Jun 30, 2024 | 89.39 Mn |
| Dec 31, 2023 | 91.82 Mn |
| Sep 30, 2023 | 118.11 Mn |
| Jun 30, 2023 | 85.02 Mn |
| Dec 31, 2022 | 299.33 Mn |
| Mar 31, 2022 | 242.60 Mn |
| Dec 31, 2021 | 73.54 Mn |
| Sep 30, 2021 | 317.19 Mn |
| Jun 30, 2021 | 333.79 Mn |
| Mar 31, 2021 | 314.59 Mn |
| Dec 31, 2020 | 73.54 Mn |
| Sep 30, 2020 | 84.59 Mn |
| Dec 31, 2019 | 42.31 Mn |